Targeting the oxidative regulation of Kv1.5 (either its acute oxidative augmentation of activity or controlling its oxidant-induced internalization/degradation) represents a novel and potentially important strategy for regulating its functional expression and activity as an approach to the management of AF. This evidence concerns the gene KCNA5 and atrial fibrillation.